chemotherapy
Health care providers have been reporting unprecedented shortages of prescription drugs, including vital medications such as chemotherapies and antibiotics. Under current law, the FDA has no power to act, so two senators have introduced a bill to help government get a handle on the problem.
Drug Shortages: A Deadly Problem With No Cure in Sight
11:00AM 1/11/2011
If gasoline or jobs or milk were in short supply, we'd all know about it. But unknown to most Americans, the country is now in the grips of a life-threatening drug shortage. Medical professionals are quite aware of it, however, and they're deeply concerned.
This little-known biopharmaceutical outfit has signed not just one but seven partnership pacts with Big Pharmas to help develop some of its products. Micromet's No. 1 appeal: It's developing novel antibody-based drugs to treat cancer, inflammatory and autoimmune diseases.
What's Spectrum's particular allure? Beyond being the subject of takeover rumor, it has two oncology drugs approved by the Food and Drug Administration that are already on the market, plus two other promising drugs that are in late-stage clinical trials.
Traditional chemotherapy for cancer patients is as dreaded as the disease itself. But Delcath's "Chemosaturation System," which is doing well so far in tests, promises to deliver treatments far more precisely, thus limiting side effects.
Talking Comedy, Canada and Cancer with the Kids in the Hall
7:30AM 8/20/2010
It's been 15 years since The Kids in the Hall, the seminal sketch comedy show by the Canadian troupe of the same name, went off the air. Now they're finally back with a new show, Death Comes to Town.
Promising New Developments on the Breast Cancer Front
5:30PM 12/14/2009
Company News, Technology, Health Care, Sanofi Aventis, GlaxoSmithKline
The San Antonio Breast Cancer Symposium, held Dec. 9-13, brought mostly good news for breast cancer patients and drugmakers. And that's a welcome development: Aside from non-melanoma skin cancer, breast cancer is the most common form of cancer in women and the second-leading cause of cancer death...
More Stories
Market Movers
| Symbol | Last | Change / % | Volume |
|---|
Most Actives
| 8.08 | -0.11 -1.28% | 179.08M | |
| 2.20 | +0.26 +13.14% | 100.91M | |
| 12.42 | -0.28 -2.17% | 34.59M | |
| 18.83 | -0.30 -1.57% | 32.37M |
% Gainers
| 32.45 | +8.55 +35.77% | 14.79M | |
| 89.14 | +12.75 +16.69% | 9.78M | |
| 2.20 | +0.26 +13.14% | 100.91M | |
| 20.14 | +2.27 +12.70% | 128,010 |
% Losers
DailyFinance Wire
- 4 Money-Etiquette Questions Answered
- Walmart's New Health Food Push: Is It Too Hard to Swallow?
- Newlyweds, Don't Let the IRS Spoil Your Honeymoon
- Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger
- Why Groupon Will Never Be Great Again
- Why Used Car Bargains Are Getting Harder to Find
- 5 Reasons Facebook Stock May Be a Better Buy Than You Think
Newswire
- Greek PM says default would lead to "chaos"
- Budget deficit drops to $27 billion in January
- Turbo-traders take Bank of America for a ride
- Stocks fall sharply as Greek deal is held up
- Bernanke: Weak housing has hurt consumer...
- Trade deficit widens to $48.8 billion in...
- Feds investigate door fires in 2007 Camrys,...
- Review: Netflix and Hulu's new scripted...
- Mid-day Movers (CIE, AMRS, IPSU, MOVE, LNKD)
- Petrobras Shares Volatile on $225 Billion Development Plan (PBR)
- Morning Movers (CIE, ALU, LNKD, AMRS, XIDE)
- AEP Dividend Growth Still Looks Safe Ahead (AEP)
- Arch Coal Tumbles on Earnings, Forecast (ACI, ANR, PCX, BTU, CNX)
- 2011 Trade Deficit Hits 3-Year High, Over $550 Billion
- Today’s Best Market Rumors (2/10/2012) Apple iPad, Google Entertainment
- Top Analyst Upgrades & Downgrades (ALTR, AMSC, BIIB, CELG, COH, CSTR, COP, FSLR, GILD, HAIN, MA, RF, TRLG)
Follow Us
